Search results
Is intermittent fasting better than counting calories? Maybe not, but you might stick with it
WSYR 9 Syracuse· 5 days agoAs weight-loss plans go, it’s easy to see the allure of intermittent fasting: Eat what you want, but...
Clinical trials: A significant part of cancer care
Greensboro News & Record· 4 days agoA cancer diagnosis is an emotional experience. Learning that you have cancer can create feelings of hopelessness, fear and sadness. This is especially...
Cancer patients say they were turned away from New Mexico hospital
The Independent via Yahoo News· 1 day agoLimited providers, long travel times and low recruitment to clinical trials all negatively impact...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 1 day agoIn the pharmaceutical business, research to develop candidate drugs is never guaranteed to pay off,...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 1 day agoWhile its existing drug portfolio is doing quite well -- generating $6.7 billion in sales last...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 3 days agoThis is a valuable alternative to the lengthy traditional approval process, but it comes with the...
What’s wrong with your brain? It could come down to what you need more of each night
Miami Herald via Yahoo News· 1 day agoHowever, Biogen, the drugmaker behind both treatments, is discontinuing Aduhelm, which was...
Rheumatologists Deserve Better Pay, Survey Respondents Say
Medscape· 4 days agoMore than 40% of respondents said they picked up additional work to boost their income.
Stronger oversight of AI needed in medical devices, ECRI CEO says
MedTech Dive via Yahoo Finance· 1 day agoWhile this is still not a slam dunk, at least we are aware of it now and taking care of it in ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 3 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...